ClinicalTrials.Veeva

Menu

Cardiovascular and Cerebrovascular Control in Healthy Subjects (CardioSan)

S

San Donato Group (GSD)

Status

Enrolling

Conditions

Healthy
Autonomic Nervous System
Cerebral Autoregulation

Treatments

Diagnostic Test: active standing

Study type

Observational

Funder types

Other

Identifiers

NCT05706532
CardioSan

Details and patient eligibility

About

The aim of the study is to evaluate autonomic function and cerebrovascular control in 60 healthy subjects by means of noninvasive analysis of time series variability.

To this extent, heart period, systolic and mean arterial blood pressure, cerebral blood velocity, peripheral resistances, respiration will be recorded from subjects during an orthostatic challenge.

The interactions between autonomic cardiovascular function, cerebrovascular and peripheral control will be evaluated exploiting the most advanced signal processing techniques.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age >18
  • sinus rhythm
  • informed consent signed

Exclusion criteria

  • age <18
  • presence of autonomic nervous system diseases or dysfunctions

Trial design

60 participants in 1 patient group

Healthy
Description:
60 healthy subjects; age \>18; sinus rhythm; absence of autonomic diseases or dysfunctions.
Treatment:
Diagnostic Test: active standing

Trial contacts and locations

1

Loading...

Central trial contact

Vlasta Bari, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems